Information updates

Updated ASCIA anaphylaxis e-training courses

20 February 2020

All versions of ASCIA anaphylaxis e-training courses have been updated in 2020 to include recent changes to ASCIA Action Plans and Guidelines.  These courses are available at:

ASCIA anaphylaxis e-training courses continue to lead the world in providing accessible, consistent and evidence-based training for schools, early childhood education/care (ECEC), health professionals, first aid providers, patients, consumers and carers. More than 100,000 people were trained in the past year using ASCIA anaphylaxis e-training courses and more than 20,000 people have already registered over the past month for ASCIA anaphylaxis e-training courses for schools, ECEC and community.

All ASCIA anaphylaxis e-training courses now include the following changes to ASCIA Action Plans and Guidelines:

  • The weight range for adrenaline autoinjectors (150 mcg) has changed from 10-20kg to 7.5-20kg, to be consistent with ASCIA Guidelines and consensus expert opinion.
  • The section for the doctor or nurse practitioner to complete in the RED and GREEN plans is more detailed and clearer.
  • The ORANGE plan (used mostly as a poster) has a new title “ASCIA First Aid Plan for Anaphylaxis” and translated versions of this plan are available on the ASCIA website.

ASCIA recently lodged a pre-budget submission to support expansion and further development of ASCIA allergy and anaphylaxis online educational resources and e-training courses, through a request for funding for three years (2020-2023) from the federal government in the 2020-2021 budget. The funding would also enable ASCIA to continue providing ASCIA anaphylaxis e-training courses free of charge. This submission is available on the ASCIA website

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.